IRIS Accounts Production v23.4.0.336 14312585 Board of Directors 23.8.22 31.8.23 31.8.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh143125852022-08-22143125852023-08-31143125852022-08-232023-08-31143125852022-08-2214312585ns15:EnglandWales2022-08-232023-08-3114312585ns14:PoundSterling2022-08-232023-08-3114312585ns10:Director12022-08-232023-08-3114312585ns10:PrivateLimitedCompanyLtd2022-08-232023-08-3114312585ns10:SmallEntities2022-08-232023-08-3114312585ns10:AuditExempt-NoAccountantsReport2022-08-232023-08-3114312585ns10:SmallCompaniesRegimeForDirectorsReport2022-08-232023-08-3114312585ns10:SmallCompaniesRegimeForAccounts2022-08-232023-08-3114312585ns10:FullAccounts2022-08-232023-08-3114312585ns10:Director22022-08-232023-08-3114312585ns10:RegisteredOffice2022-08-232023-08-3114312585ns5:CurrentFinancialInstruments2023-08-3114312585ns5:Non-currentFinancialInstruments2023-08-3114312585ns5:ShareCapital2023-08-3114312585ns5:RetainedEarningsAccumulatedLosses2023-08-3114312585ns5:FurnitureFittings2022-08-232023-08-3114312585ns5:ComputerEquipment2022-08-232023-08-3114312585ns5:FurnitureFittings2023-08-3114312585ns5:ComputerEquipment2023-08-3114312585ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-08-3114312585ns5:Non-currentFinancialInstruments2022-08-232023-08-31
REGISTERED NUMBER: 14312585 (England and Wales)















Unaudited Financial Statements

for the Period 23rd August 2022 to 31st August 2023

for

Embla Health UK Limited

Embla Health UK Limited (Registered number: 14312585)






Contents of the Financial Statements
for the Period 23rd August 2022 to 31st August 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Embla Health UK Limited

Company Information
for the Period 23rd August 2022 to 31st August 2023







DIRECTORS: L W A Axelsen
N Syhler





REGISTERED OFFICE: 34-35 Clarges Street
Mayfair
London
W1J 7EJ





REGISTERED NUMBER: 14312585 (England and Wales)





ACCOUNTANTS: Sampson Fielding Ltd
34 - 35 Clarges Street
Mayfair
London
W1J 7EJ

Embla Health UK Limited (Registered number: 14312585)

Balance Sheet
31st August 2023

Notes £    £   
FIXED ASSETS
Tangible assets 4 16,519

CURRENT ASSETS
Stocks 18,720
Debtors 5 157,973
Cash at bank 38,551
215,244
CREDITORS
Amounts falling due within one year 6 130,474
NET CURRENT ASSETS 84,770
TOTAL ASSETS LESS CURRENT LIABILITIES 101,289

CREDITORS
Amounts falling due after more than one year 7 (174,045 )

PROVISIONS FOR LIABILITIES (4,130 )
NET LIABILITIES (76,886 )

CAPITAL AND RESERVES
Called up share capital 300,001
Retained earnings (376,887 )
(76,886 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31st August 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31st August 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20th March 2024 and were signed on its behalf by:





N Syhler - Director


Embla Health UK Limited (Registered number: 14312585)

Notes to the Financial Statements
for the Period 23rd August 2022 to 31st August 2023

1. STATUTORY INFORMATION

Embla Health UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Significant judgements and estimates
Estimates of the useful economic lives of fixed assets have been made in order to include depreciation and amortisation rates comparable with the rate at which the value of the assets should be recognised in the Statement of Comprehensive Income. No other estimates of a material nature have been included in the accounts.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures and fittings - Straight line over 7 years
Computer equipment - straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Embla Health UK Limited (Registered number: 14312585)

Notes to the Financial Statements - continued
for the Period 23rd August 2022 to 31st August 2023

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Trade and other debtors
Trade and other debtors that are receivable within one year and do not constitute a financing transaction are recorded at the undiscounted amount expected to be received, net of impairment. Those that are receivable after more than one year or that constitute a financing transaction are recorded initially at fair value less transaction costs and subsequently at amortised cost, net of impairment.

Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other amounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivable, are measured, initially and subsequentially, at the undiscounted amount of the cash or other consideration, expected to be paid or received. However if the arrangements of a short term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms of financed at a rate of interest that is not market rate or in case of an outright short term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evident of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate, which is approximation of the amount that the Company would receive for the asset if it were to be sold at the Balance Sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and in hand and short term deposits with an original maturity date of three months or less.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 5 .

Embla Health UK Limited (Registered number: 14312585)

Notes to the Financial Statements - continued
for the Period 23rd August 2022 to 31st August 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
Additions 800 18,510 19,310
At 31st August 2023 800 18,510 19,310
DEPRECIATION
Charge for period 29 2,762 2,791
At 31st August 2023 29 2,762 2,791
NET BOOK VALUE
At 31st August 2023 771 15,748 16,519

5. DEBTORS
£   
Amounts falling due within one year:
Trade debtors 12,668
Other debtors 765
Prepayments 15,225
28,658

Amounts falling due after more than one year:
Deferred tax asset 129,315

Aggregate amounts 157,973

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade creditors 6,512
Amounts owed to group undertakings 82,636
Social security and other taxes 17,461
Pension payable 3,348
Deferred income 5,153
Accrued expenses 15,364
130,474

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
£   
Amounts owed to group undertakings 174,045

This is an intercompany loan repayable after five years